Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Foscarnet Versus Vidarabine for Acyclovir-Resistant Herpes Simplex in AIDS Patients
NCT00000985Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of foscarnet sodium, vidarabine in herpes simplex (HSV), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
foscarnet sodiumvidarabine
03
Conditions
herpes simplex (HSV)
Beyond the preview
Go deeper on NCT00000985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000985.